Seer Inc Ordinary Shares - Class A SEER 深 沪
已收盘 10-31 16:00:00 美东时间
2.21
-0.020
-0.90%
华盛通- 最 高2.26
- 今 开2.24
- 成交量 3.45万股
- 最 低 2.20
- 昨 收 2.23
- 总市值 1.25亿
- 52周最高 2.625
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 1.62
- 委 比 32.20%
- 总股本 5633.93万
- 历史最高 86.55
- 量 比 0.29
- 振 幅 2.69%
- 历史最低 1.455
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Seer to Participate in Upcoming November Investor Conferences
Seer, Inc. announced that its management will participate in two upcoming investor conferences: the UBS Global Healthcare Conference on November 12th and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20th. Live webcasts and archived replays of the sessions will be available on Seer’s Investor website. Seer, a leader in deep, unbiased proteomics, offers advanced solutions for biological insights through...
10-29 20:05
Mark Cuban Warns Ending Billionaires Would Destroy Market and Erase Savings: 'Should We Get Rid of the Stock Market?'
Mark Cuban says that the elimination of billionaires would trigger a stock market crash, potentially erasing the savings of average Americans.
10-27 00:31
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) invests $4 million in exchange for a 30% ownership stake and joint control in RedHill's Talicia business U.S. co-commercialization partnership ...
10-20 21:00
全球研发 | 全球首个胸腺上皮肿瘤治疗ADC！复宏汉霖PD-L1 ADC HLX...
HLX43获得FDA孤儿药资格认定用于胸腺上皮肿瘤的治疗，意味着该产品后续在美国的研发、注册及商业化等方面将享受一定的政策支持 胸腺癌是胸腺上皮肿瘤中一类相对罕...
10-20 17:44
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
Seer, Inc. will participate in the ASHG 2025 Annual Meeting, showcasing how its Proteograph Product Suite enhances multi-omic translational studies and identifies protein isoform-specific biomarkers. The company will host a CoLab session, "Advancing Precision Medicine Through Multi-Omics," featuring insights from xenotransplantation and fibrosis research. Additionally, independent studies using Seer’s platform will demonstrate its role in integra...
10-10 11:00
MrBeast Went From Hiring Comedians And Laptop Salesmen From Best Buy To Building A 400-Person YouTube Empire: 'I Wish I Had A Mentor'
MrBeast revealed that his $2.6 billion YouTube empire began with chaotic early days, when he hired comedians and Best Buy employees as his first team before growing into a 400-person global operation.
10-09 09:12
Inside MrBeast's $5 Billion Generosity Machine — and the Hidden Costs Behind It
Internet sensation Jimmy Donaldson, better known as MrBeast, has successfully established an entertainment empire valued at over $5 billion.
09-29 03:11
SEERai™ by Galorath Wins SiliconANGLE TechForward Award with Industry-First Agentic Artificial Intelligence
SEERai Recognized as the Industry's First Agentic AI Platform Transforming Cost, Schedule, and Risk Planning in Secure Enterprise Environments LONG BEACH, Calif., Sept. 16, 2025 /PRNewswire/...
09-16 18:15
MrBeast To Run For President? $1.2 Million Polymarket Bet Could Be Dead Money
Ahead of the 2028 presidential election, Polymarket is attracting millions of dollars in wagers, including on candidates that can't legally run.
09-05 23:43
Seer Appoints Isaac Ro to its Board of Directors
Seer, Inc. has appointed Isaac Ro to its Board of Directors. Ro, known for his financial leadership and extensive experience in life sciences and healthcare, brings valuable expertise to Seer as it continues to advance its proteomics platform. Ro currently serves as a Partner at Catalio Capital Management and has a proven track record of guiding companies through transformative growth. His appointment reflects Seer's commitment to expanding its i...
09-02 11:00
